NCT04656795View on ClinicalTrials.gov

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

December 4, 2021

Study Completion Date

December 9, 2021

Conditions
Renal ImpairmentNormal Renal Function
Interventions
DRUG

MT-7117

MT-7117

Trial Locations (1)

Unknown

Clinical Research Services (CRS) Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY